{"schema":"sb.node.v1","id":"sb:e/a8494cec2535c4a0ecb1a7c5","kind":"entity","label":{"text":"aems","locale":"en"},"identity":{"anchor":"label:en:aems","strength":"label"},"asOf":{"knowledgeCutoff":"2026-10-10T23:27:45.667496+00:00","snapshot":"deploy 620feaefbcb4ce84dcc095fdb4529186923775d8"},"lens":{"kind":"public"},"build":{"plane":"projected","builtFrom":["entity_graph.slim.json","entity_receipts (deploy asset)","event_graph.json","truth_records (deploy asset)","corroborated_record.json"],"rule":"node-projection.entity@v1"},"standing":{"evidence":{"supporting":12,"separatePublishers":1,"basis":"documents that mention the subject and the outlets that carried them; a mention is evidence the referent is in use, not evidence about any claim","receiptsOnTopic":{"state":"measured","share":0.917,"named":11,"of":12,"basis":"documents whose own title or summary lead names the subject, over every counted document that mentions it anywhere (the entity graph's measurement); receipts are drawn from the former only"}},"admission":{"state":"provisional","reason":"entity graph provenance 'observed'; the node carries no promotion receipt in v1","policy":"EQ-PROMOTION (receipt not carried)"},"disposition":{"state":"served","reason":"public record"},"validity":{"from":"2026-04-06","to":"2026-10-09","basis":"first and last day we saw it mentioned; not the subject's own lifetime"},"measurement":{"state":"partial","blind":["assertion coverage 0.917: about 8% of mentions carry no typed assertion"]}},"dimensions":{"domains":["pharma-regulatory","biotech_pharma"],"activeDays":6,"assertions":{"regulatory-approval":11}},"up":[],"upNote":"An entity is a root: it is contained by nothing. Pan out by following R.","children":{"count":11,"byKind":{"observation":11},"items":[{"id":"sb:o/c3002b132d283f360e12aae1","kind":"observation","label":"FDA · 2026-10-01 · FDA Adverse Event Monitoring System (AEMS) – E2B(R3) Data Standards","url":"http://www.fda.gov/drugs/fda-adverse-event-monitoring-system-aems/fda-adverse-event-monitoring-system-aems-e2br3-data-standards"},{"id":"sb:o/e0bb3d946b4af2537daf333f","kind":"observation","label":"FDA · 2026-10-01 · FDA Adverse Event Monitoring System (AEMS) Electronic Submissions","url":"http://www.fda.gov/drugs/fda-adverse-event-monitoring-system-aems/fda-adverse-event-monitoring-system-aems-electronic-submissions"},{"id":"sb:o/4f7987d2220af89922a6d7fc","kind":"observation","label":"FDA Drug News · 2026-07-01 · January - March 2026 | New Safety Information or Potential Signals of Serious Risks Identified by the FDA Adverse Event Monitoring System (AEMS)","url":"http://www.fda.gov/drugs/fda-adverse-event-monitoring-system-aems/january-march-2026-new-safety-information-or-potential-signals-serious-risks-identified-fda-adverse"},{"id":"sb:o/928b146333ff0a9f0db59761","kind":"observation","label":"FDA Drug News · 2026-06-13 · October - December 2024 | New Safety Information or Potential Signals of Serious Risks Identified from the FDA Adverse Event Monitoring System (AEMS)","url":"http://www.fda.gov/drugs/fda-adverse-event-monitoring-system-aems/october-december-2024-new-safety-information-or-potential-signals-serious-risks-identified-fda"},{"id":"sb:o/1afc5db92e784648f280aef3","kind":"observation","label":"FDA Drug News · 2026-06-13 · October - December 2022 | New Safety Information or Potential Signals of Serious Risks Identified from the FDA Adverse Event Monitoring System (AEMS)","url":"http://www.fda.gov/drugs/fda-adverse-event-monitoring-system-aems/october-december-2022-new-safety-information-or-potential-signals-serious-risks-identified-fda"},{"id":"sb:o/fb546e0cca842d551c73a237","kind":"observation","label":"FDA Drug News · 2026-06-13 · July - September 2022 | New Safety Information or Potential Signals of Serious Risks Identified from the FDA Adverse Event Monitoring System (AEMS)","url":"http://www.fda.gov/drugs/fda-adverse-event-monitoring-system-aems/july-september-2022-new-safety-information-or-potential-signals-serious-risks-identified-fda-adverse"},{"id":"sb:o/9b0559d5280c726bf149689a","kind":"observation","label":"FDA Drug News · 2026-06-13 · January - March 2024 | New Safety Information or Potential Signals of Serious Risks Identified from the FDA Adverse Event Monitoring System (AEMS)","url":"http://www.fda.gov/drugs/fda-adverse-event-monitoring-system-aems/january-march-2024-new-safety-information-or-potential-signals-serious-risks-identified-fda-adverse"},{"id":"sb:o/7277c93c22878658a2df4ac9","kind":"observation","label":"FDA Drug News · 2026-06-13 · January - March 2022 | New Safety Information or Potential Signals of Serious Risks Identified from the FDA Adverse Event Monitoring System (AEMS)","url":"http://www.fda.gov/drugs/fda-adverse-event-monitoring-system-aems/january-march-2022-new-safety-information-or-potential-signals-serious-risks-identified-fda-adverse"},{"id":"sb:o/56bf345f8142cbc0d229900f","kind":"observation","label":"FDA Drug News · 2026-06-13 · April - June 2022 | New Safety Information or Potential Signals of Serious Risks Identified from the FDA Adverse Event Monitoring System (AEMS)","url":"http://www.fda.gov/drugs/fda-adverse-event-monitoring-system-aems/april-june-2022-new-safety-information-or-potential-signals-serious-risks-identified-fda-adverse"},{"id":"sb:o/79b4913671d85b9d7fbd618c","kind":"observation","label":"FDA Drug News · 2026-04-14 · New Safety Information or Potential Signals of Serious Risks Identified from the FDA Adverse Event Monitoring System (AEMS)","url":"http://www.fda.gov/drugs/fda-adverse-event-monitoring-system-aems/new-safety-information-or-potential-signals-serious-risks-identified-fda-adverse-event-monitoring"}],"cursor":"c1.eyJpZCI6InNiOmUvYTg0OTRjZWMyNTM1YzRhMGVjYjFhN2M1IiwibCI6ImNoaWxkcmVuIiwibyI6MTAsImsiOm51bGwsImEiOiIyMDI2LTEwLTEwVDIzOjI3OjQ1LjY2NzQ5NiswMDowMCJ9","order":"newest first; we keep the 11 newest receipts for this entity whose own title or summary lead (the entity graph's test) names it. Its other observations are counted in standing.evidence.supporting but are not addressable in v1"},"relations":{"count":3,"byKind":{"co-mentioned":3},"items":[{"kind":"relation","label":"co-mentioned with fda (12 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/7408cb314a1b7f784be314b4"},{"kind":"relation","label":"co-mentioned with fda adverse event (12 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/d4610f22c94f7b79747de688"},{"kind":"relation","label":"co-mentioned with monitoring system (12 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/57deeaa2255f92f73f6f2ba6"}],"cursor":null,"order":"situations first, then claims (the subject's own maintained record, then site-wide corroborated clusters; each label ends with its standing), then co-mentions by shared documents, descending. Co-mentions are the ten strongest the entity graph keeps per entity"},"edge":{"state":"continues"},"links":{"rest":"/api/v1/node/e/a8494cec2535c4a0ecb1a7c5","mcp":"traverse {\"id\":\"sb:e/a8494cec2535c4a0ecb1a7c5\"}","page":"/entity/aems/"},"limits":{"levelsPerCall":1,"pageSize":10,"maxPageSize":50,"membersMax":50,"statement":"One level per call: depth is 1 and only 1, and there is no whole-graph dump. pageSize 1-50 (default 10); a page limit is a cursor, never an edge. Members are listed up to 50. At most 60 traverse calls a minute per caller (runaway-loop protection, not a meter). One knowledge cutoff is served: the deploy's."},"actions":[{"verb":"unfold","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/a8494cec2535c4a0ecb1a7c5\",\"level\":\"children\"}"},{"verb":"fold","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/a8494cec2535c4a0ecb1a7c5\"}"},{"verb":"panOut","lit":false,"effect":"read","layer":"cantina","reason":"An entity is a root: it is contained by nothing. Pan out by following R."},{"verb":"follow","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/a8494cec2535c4a0ecb1a7c5\",\"level\":\"relations\"}"},{"verb":"receipts","lit":false,"effect":"read","layer":"cantina","reason":"receipts are the observations below this node; unfold to reach them"},{"verb":"edge","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/a8494cec2535c4a0ecb1a7c5\"}"},{"verb":"asOf","lit":false,"effect":"read","layer":"cantina","reason":"v1 serves one knowledge cutoff, this deploy's; walking an earlier cutoff needs retained history (EQ-REPLAY), which v1 does not keep"},{"verb":"switchObserver","lit":false,"effect":"read","layer":"cantina","reason":"the public record is the same for every observer; traversal through a Watch's lens is not served in v1"},{"verb":"readOriginal","lit":false,"effect":"read","layer":"cantina","reason":"no translation is applied on this node; every label is the source's own text"},{"verb":"save","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"saving applies to a configured Watch; configure one around this node first (free), then save it"},{"verb":"deliver","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"delivery applies to a saved Watch"},{"verb":"format","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"output format applies to a saved Watch"},{"verb":"deltaR","lit":false,"effect":"read","layer":"workshop","reason":"Delta R needs a saved Watch with a previous reading"},{"verb":"read","lit":false,"effect":"read","layer":"docking-bay","reason":"one-time Reads are parked until the Commander decides their shape (#938)"}]}